Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026298 · ClinicalTrials.gov registry record · NA
Asthma and Obstructive Sleep Apnea (OSA)
A NA study of Asthma and Obstructive Sleep Apnea, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 744
- Enrollment target
- 1
- Study location
NCT01026298: Completed NA study of Asthma and Obstructive Sleep Apnea, sponsored by University of Wisconsin, Madison.
NCT01026298 is a NA study of Asthma and Obstructive Sleep Apnea that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 744 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01026298, a NA study of Asthma and Obstructive Sleep Apnea, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 744 participants
- Enrollment target
- 1
- Study location
Study Summary
Obstructive sleep apnea (OSA) is a common but under-diagnosed form of sleep disordered breathing (SDB). Asthma is a common disease with rising prevalence, which continues to pose significant morbidity and costs. In spite of considerable progress in our understanding of asthma, a large number of individuals with asthma continue to have symptoms and subsequently, have a poor functional status, poor quality of life and increased health care costs. In many cases no apparent cause is found and optimal therapy does not achieve its goal. While recent data suggests that OSA is common in severe asthma, the prevalence of OSA and its predisposing factors have not been studied.
Conditions Studied
Interventions
- OTHER FDA-Approved Treatment
Study Locations (1)
Wisconsin
- Univeristy of Wisconsin Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 744 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-06-25 |
| Phase | NA |
What the finished NCT01026298 record still lists
NCT01026298 is an interventional study that assigns participants to a tested intervention. The registered 744 participants enrollment target is mid-sized for trials with a published cap, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which FDA-Approved Treatment is the first listed.
NCT01026298 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01026298 about?
NCT01026298 is a clinical study titled "Asthma and Obstructive Sleep Apnea (OSA)". Obstructive sleep apnea (OSA) is a common but under-diagnosed form of sleep disordered breathing (SDB). Asthma is a common disease with rising prevalence, which continues to pose significant morbidity and costs. In spite of considerable progress in our understanding of asthma, a large number of indi...
What is the current status of trial NCT01026298?
This trial is currently completed. It is a NA study. The enrollment target is 744 participants. The study started on 2007-03. Estimated completion is 2012-06-25.
What conditions does trial NCT01026298 study?
This clinical trial studies the following conditions: Asthma, Obstructive Sleep Apnea.
What interventions are being tested in trial NCT01026298?
The interventions under investigation include: FDA-Approved Treatment (OTHER).
Who is sponsoring clinical trial NCT01026298?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01026298 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01026298's enrollment target sits among peer trials
744 56th of 374 higher than 319 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia